Michael Giuffre

Executive

US·SEC (Form 4)

DiaMedica Therapeutics Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 04 Jun 2026 for DiaMedica Therapeutics Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Michael Giuffre: trading record in brief

Michael Giuffre has a single filing on record, published on 4 June 2026: an option exercise in DiaMedica Therapeutics Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Michael Giuffre

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

DiaMedica Therapeutics Inc. (US)

Declarations1 total

◇

Michael Giuffre

4 - Director of IssuerExecutives1 Jun 2026DiaMedica Therapeutics Inc.

0SEDI ↗

40,412 sharesOptionsTSXSEDI:4728855

1 of 1 declaration

Michael Giuffre

Insider track record

Michael Giuffre: trading record in brief

Companies and markets linked to Michael Giuffre

Related entities

Michael Giuffre

Insider track record

Michael Giuffre: trading record in brief

Companies and markets linked to Michael Giuffre

Related entities